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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S141narrowing (JSN) were assessed using OARSI atlas. T1- or T2-weighted
fat suppressed magnetic resonance imaging (MRI) was utilized to
infrapatellar fat pad maximum area, cartilage volume, cartilage defect
and bone marrow lesions (BMLs). Knee pain was assessed by self-
administered Western Ontario McMaster Osteoarthritis Index
(WOMAC) questionnaire.
Results: Infrapatellar fat pad maximum area was positively associated
with age, height, weight, and negatively with female sex (all p<0.01 in
multivariable analyses). After adjustments of age, sex, height, weight,
disease status and/or knee radiographic features, infrapatellar fat pad
maximum area was signiﬁcantly associated with decreased joint space
narrowing (OR: 0.74 to 0.78, p<0.02) and osteophytes (OR: 0.52,
p<0.01), increased knee tibial and patellar cartilage volume (beta: 59 to
165 mm3/cm2, all P<0.001), decreased tibial cartilage defects (OR: 0.54
to 0.58, all p<0.01), decreased BMLs (OR: 0.77, p<0.01), and decreased
knee pain (pain on ﬂat surface, OR: 0.79, P<0.05; pain on stairs, OR:
0.84, p¼0.06). Longitudinally, infrapatellar fat pad maximum area was
signiﬁcantly associated with less loss of cartilage volume (medial tibial,
beta: 0.8% per cm2, p¼0.01; lateral tibial, beta: 0.7% per cm2, p¼0.019),
and less increase in cartilage defects (medial tibiofemoral, OR: 0.65,
p¼0.003).
Conclusions: Infrapatellar fat pad maximum area is associated with
decreased knee pain, radiographic OA, BMLs, and less cartilage loss and
defect progression/development, suggesting that infrapatellar fat pad
may be protective against knee OA in older adults.
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Purpose:Much of the literature on predictors of outcomes and rates of
complications following total hip arthroplasty (THA) has focused on the
experience in patients with osteoarthritis (OA). However, THA is also
used to treat patients with rheumatoid arthritis (RA), a fundamentally
different condition in terms of pathogenesis, prognosis and medical
management. Studies that have examined outcomes following THA in
patients with RA have been limited by the use of variable deﬁnitions for
RA, many of which have not been validated. Thus, the risk for
misclassiﬁcation bias, with crossover between RA, OA and other
inﬂammatory arthritides (IA) is potentially high, raising questions about
the validity of ﬁndings. We took advantage of a recently validated
algorithm for RA using administrative data, with a high speciﬁcity and
positive predictive value, to determine the prevalence of RA amongst
THA recipients, and to compare of complications rates of THA in
patients with RA versus OA.
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective THA between 2002-2009 utilizing administrative
databases from Ontario, Canada. We excluded those who received
a primary or revision arthroplasty of the hip or knee prior to April 1,
2002, those whose ﬁrst procedure was non-elective (e.g. for cancer,
fracture, or injury), or those with a history of hip dysplasia. RA was
deﬁned using the following validated algorithm: a hospitalization for
RA, or 3 physician RA OHIP claims with at least 1 claim by a specialist
[rheumatologist, orthopedic surgeon or internist] in a 2y period).
Recipients with diagnostic codes suggesting IA (e.g., psoriatic arthritis,
lupus, etc) or with a code for RA but who did not meet criteria were
classiﬁed as having IA. All remaining patients were deemed to have OA.
We compared baseline characteristics and rates of complications
following the index THA for recipients with RA versus OA. Generalized
estimating equations were used to determine the relationship between
arthritis type and the occurrence of speciﬁc complications (within 90d:
DVT/PE, mortality; within 2y: dislocation, infection, peri-prosthetic
fracture and revision), deﬁned using validated algorithms, controlling
for potential confounders (income quintile, rurality, and provider
volume) and for clustering by surgeons.
Results: Between April 1, 2002 and March 31, 2009, there were 43,997
patients who received their ﬁrst THA (OA: 37,881 - 86%; IA: 4,953 - 11%;
RA: 1,163 - 3%). Compared with THA recipients who had OA, those with
RA were more likely to be female (73.5% versus 53.9%, p<0.0001), were
younger (mean age 62.4y vs 66.3y, p<0.0001), and had greater co-
morbidity (Charlson score of 2+: 9.8% vs 4.4%, p<0.0001). Controlling
for these differences, and other potential confounders, THA recipientswith RA were more likely to experience hip dislocation (adjusted OR
1.92, 95%CI 1.27, 2.89, p<0.0001) and less likely to experience DVT/PE
(adjusted OR 0.32, 95%CI 0.14, 0.76, p¼0.007), but were similarly likely
to experience all other complications: infection (adjusted OR 1.07, 95%CI
0.59, 1.92), early revision (adjusted OR 1.39, 95%CI 0.81, 2.41), peri-
prosthetic fracture (adjusted OR 1.22, 95%CI 0.56, 2.66) and death
within 90d (adjusted OR 1.86, 95%CI 0.96, 3.60).
Conclusions: In a population cohort undergoing their ﬁrst primary
THA, w3% of recipients had a diagnosis of RA. These patients were at
increased risk of dislocation within 2years of their surgery, at lower risk
for DVT/PE, and at similar risk for infection, fracture, death or early
revision following THA. To our knowledge, this is the ﬁrst study that has
utilized a validated algorithm to identify THA recipients with RA,
thereby increasing the validity of our ﬁndings, and aiding patient-
physician decision-making around joint replacement in patients with
RA. Further research is required to elucidate potential explanations for
the higher rates of dislocation following THA in RA versus OA.
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Purpose:Much of the literature on predictors of outcomes and rates of
complications following total knee arthroplasty (TKA) has focused on
the experience in patients with osteoarthritis (OA). However, TKA is also
used to treat patients with rheumatoid arthritis (RA), a condition that
fundamentally differs from OA in terms of pathogenesis, prognosis and
medical management. Studies that have examined outcomes following
TKA in patients with RA have been limited by the use of variable deﬁ-
nitions for RA, many of which have not been validated. Thus, the risk for
misclassiﬁcation bias, with crossover between RA, OA and other
inﬂammatory arthritides (IA) is potentially high, raising questions about
the validity of ﬁndings. We took advantage of a recently validated
algorithm for RA using administrative data, which has been shown to
have a high speciﬁcity and positive predictive value, to determine the
prevalence of RA amongst TKA recipients, and to compare of compli-
cations rates of TKA in patients with RA versus OA.
Methods: We deﬁned a cohort of patients who received their ﬁrst
primary elective TKA between 2002-2009 utilizing health administra-
tive data from Ontario, Canada. We excluded those who had received
a primary or revision arthroplasty of the hip or knee prior to April 1,
2002, and those whose ﬁrst procedure was non-elective (e.g. for cancer,
fracture, or external cause of injury). RAwas deﬁned using the following
validated algorithm: a hospitalization for RA (ICD-10 code 714), or 3
physician RA OHIP claims with at least 1 claim by a specialist [rheu-
matologist, orthopedic surgeon or internist] in a 2 year period). TKA
recipients with diagnostic codes suggesting IA (e.g., diagnostic code for
psoriatic arthritis, lupus, etc) or with a code for RA but who did not
meet criteria for RA were classiﬁed as having IA. All remaining patients
were deemed to have OA. We compared baseline characteristics and
rates of complications following the index TKA for recipients with RA
versus OA. Generalized estimating equations were used to determine
the relationship between arthritis type and the occurrence of speciﬁc
complications (within 90d: DVT/PE, mortality; within 2y: infection and
revision), deﬁned using validated algorithms, controlling for potential
confounders (income quintile, rurality, prior intra-articular injection,
and provider volume) and for clustering by surgeons.
Results: Between April 1, 2002 and March 31, 2009, there were 71,793
patients who received their ﬁrst TKA (OA: 59,564 - 83%; IA: 9,537 - 13%;
RA: 2,692 - 4%). TKA recipients with RA were more likely to be female
(75.5% versus 60.6%, p<0.0001), younger (mean age 65.4y versus 67.7y,
p<0.0001), and had greater co-morbidity (Charlson score of 2+: 7.4%
versus 4.3%, p<0.0001). Controlling for these differences, and for other
potential confounders, TKA recipients with RA were more likely than
those with OA to experience infection (adjusted OR 1.52, 95%CI 1.09,
2.10, p¼0.007), but did not differ signiﬁcantly with respect to likelihood
for experiencing: DVT/PE (adjusted OR 0.76, 95%CI 0.53, 1.08), early
revision (adjusted OR 0.84, 95%CI 0.57, 1.23), and death within 90d
(adjusted OR 1.08, 95%CI 0.61, 1.93).
Conclusions: In a population inception cohort undergoing their ﬁrst
primary TKA,w4% of recipients had a diagnosis of RA. Compared with
TKA recipients with OA, those with RA were more likely to experience
